FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289443453> ?p ?o ?g. }

• W4289443453 endingPage "2325" @default.
• W4289443453 startingPage "2316" @default.
• W4289443453 abstract "In past decades, regular porous architectures have received a great amount of attention because of their versatile functions and applications derived from their efficient adsorption of various guests. However, most reported porous architectures exist only in the solid state. Therefore, their applications as biomaterials may face several challenges, such as phase separation, slow degradation, and long-term accumulation in the body. This Account summarizes our efforts with respect to the development and biomedical applications of water-soluble 3D diamondoid supramolecular organic frameworks (dSOFs), a family of supramolecular polymers that possess intrinsic regular nanoscale porosity.dSOFs have been constructed from tetratopic components and cucurbit[8]uril (CB[8]) through hydrophobically driven encapsulation by CB[8] for intermolecular dimers formed by peripheral aromatic subunits of the tetratopic components in water. All dSOFs exhibit porosity regularity or periodicity in aqueous solution, which is confirmed by solution-phase synchrotron SAXS and XRD experiments. Dynamic light scattering (DLS) reveals that their sizes range from 50 to 150 nm, depending on the concentrations of the components. As nonequilibrium supramolecular architectures, dSOFs can maintain their nanoscale sizes at micromolar concentrations for dozens of hours. Their diamondoid pores have aperture sizes ranging from 2.1 to 3.6 nm, whereas their water solubility and porosity regularity allow them to rapidly include discrete guests driven by ion-pair electrostatic attraction, hydrophobicity, or a combination of the two interactions. The guests may be small molecule or large macromolecular drugs, photodynamic agents (PDAs), or DNA.The rapid inclusion of bioactive guests into dSOFs has led to two important biofunctions. The first is to function as antidotes through including residual drugs. For heparins, the inclusion results in full neutralization of their anticoagulant activity. For clinically used porphyrin PDAs, the inclusion can alleviate their long-term posttreatment phototoxicity but does not reduce their photodynamic efficacy. The second is to function as in situ loading carriers for the intracellular delivery of antitumor drugs or DNA. Their nanoscale sizes bring out their ability to overcome the multidrug resistance of tumor cells, which leads to a remarkable enhancement of the bioactivity of the included drugs. By conjugating aldoxorubicin to tetrahedral components, albumin-mimicking prodrugs have also been constructed, which conspicuously improves the efficacy of aldoxorubicin toward multi-drug-resistant tumors through the delivery of the frameworks. As new supramolecular drugs and carriers, dSOFs are generally biocompatible. Thus, further efforts might lead to medical benefits in the future." @default.
• W4289443453 created "2022-08-02" @default.
• W4289443453 creator A5023798621 @default.
• W4289443453 creator A5033268459 @default.
• W4289443453 creator A5054644087 @default.
• W4289443453 creator A5062243959 @default.
• W4289443453 creator A5076177439 @default.
• W4289443453 date "2022-08-02" @default.
• W4289443453 modified "2023-10-16" @default.
• W4289443453 title "Supramolecular Organic Frameworks: Exploring Water-Soluble, Regular Nanopores for Biomedical Applications" @default.
• W4289443453 cites W1929721907 @default.
• W4289443453 cites W1975341277 @default.
• W4289443453 cites W1979539399 @default.
• W4289443453 cites W1982810365 @default.
• W4289443453 cites W1985263855 @default.
• W4289443453 cites W1995958134 @default.
• W4289443453 cites W1998506213 @default.
• W4289443453 cites W2024179442 @default.
• W4289443453 cites W2043672286 @default.
• W4289443453 cites W2058090403 @default.
• W4289443453 cites W2079122204 @default.
• W4289443453 cites W2083214619 @default.
• W4289443453 cites W2092482435 @default.
• W4289443453 cites W2096672498 @default.
• W4289443453 cites W2109196266 @default.
• W4289443453 cites W2115112321 @default.
• W4289443453 cites W2117508948 @default.
• W4289443453 cites W2153464333 @default.
• W4289443453 cites W2170421456 @default.
• W4289443453 cites W2192072986 @default.
• W4289443453 cites W2278726896 @default.
• W4289443453 cites W2300671107 @default.
• W4289443453 cites W2323254267 @default.
• W4289443453 cites W2325602836 @default.
• W4289443453 cites W2386172027 @default.
• W4289443453 cites W2391736880 @default.
• W4289443453 cites W2570345505 @default.
• W4289443453 cites W2573664000 @default.
• W4289443453 cites W2598224385 @default.
• W4289443453 cites W2768730523 @default.
• W4289443453 cites W2792431156 @default.
• W4289443453 cites W2803217300 @default.
• W4289443453 cites W2809722643 @default.
• W4289443453 cites W2899404046 @default.
• W4289443453 cites W2921581841 @default.
• W4289443453 cites W2939846960 @default.
• W4289443453 cites W2967748279 @default.
• W4289443453 cites W2988690198 @default.
• W4289443453 cites W2992138242 @default.
• W4289443453 cites W3042147474 @default.
• W4289443453 cites W3092641284 @default.
• W4289443453 cites W3112062118 @default.
• W4289443453 cites W3173560393 @default.
• W4289443453 cites W3199601805 @default.
• W4289443453 cites W4200456434 @default.
• W4289443453 cites W4205584235 @default.
• W4289443453 cites W4210963845 @default.
• W4289443453 cites W4220991078 @default.
• W4289443453 cites W4225272084 @default.
• W4289443453 cites W4226052856 @default.
• W4289443453 doi "https://doi.org/10.1021/acs.accounts.2c00335" @default.
• W4289443453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35916446" @default.
• W4289443453 hasPublicationYear "2022" @default.
• W4289443453 type Work @default.
• W4289443453 citedByCount "14" @default.
• W4289443453 countsByYear W42894434532022 @default.
• W4289443453 countsByYear W42894434532023 @default.
• W4289443453 crossrefType "journal-article" @default.
• W4289443453 hasAuthorship W4289443453A5023798621 @default.
• W4289443453 hasAuthorship W4289443453A5033268459 @default.
• W4289443453 hasAuthorship W4289443453A5054644087 @default.
• W4289443453 hasAuthorship W4289443453A5062243959 @default.
• W4289443453 hasAuthorship W4289443453A5076177439 @default.
• W4289443453 hasConcept C120665830 @default.
• W4289443453 hasConcept C121332964 @default.
• W4289443453 hasConcept C127413603 @default.
• W4289443453 hasConcept C130929614 @default.
• W4289443453 hasConcept C131888329 @default.
• W4289443453 hasConcept C141795571 @default.
• W4289443453 hasConcept C159467904 @default.
• W4289443453 hasConcept C159985019 @default.
• W4289443453 hasConcept C166950319 @default.
• W4289443453 hasConcept C171250308 @default.
• W4289443453 hasConcept C178790620 @default.
• W4289443453 hasConcept C185592680 @default.
• W4289443453 hasConcept C191486275 @default.
• W4289443453 hasConcept C192562407 @default.
• W4289443453 hasConcept C32909587 @default.
• W4289443453 hasConcept C42360764 @default.
• W4289443453 hasConcept C45206210 @default.
• W4289443453 hasConcept C6648577 @default.
• W4289443453 hasConcept C90104038 @default.
• W4289443453 hasConcept C93275456 @default.
• W4289443453 hasConceptScore W4289443453C120665830 @default.
• W4289443453 hasConceptScore W4289443453C121332964 @default.
• W4289443453 hasConceptScore W4289443453C127413603 @default.
• W4289443453 hasConceptScore W4289443453C130929614 @default.
• W4289443453 hasConceptScore W4289443453C131888329 @default.

• next